Bioterrorism Publications

Suggested Reading

• Albert MR, et al. The last smallpox epidemic in Boston and the vaccination controversy, 1901-1903. New Engl J Med. 2001;344:375-9.

• American Academy of Pediatrics. Chemical-biological terrorism and its impact on children. Pediatrics. 2000;105:662-70.

• Bradley RN. Health care facility preparation for weapons of mass destruction. Prehospital Emergency Care. 2000;4:261-9.

• Cieslak TJ, et al. A field-expedient algorithmic approach to the clinical management of chemical and biological casualties. Military Medicine. 2000;165:659-62.

• Centers for Disease Control and Prevention. Biological and Chemical Terrorism: Strategic Plan for Preparedness and Response. MMWR. 2000 Apr 21;49(RR04):1-14.

• Centers for Disease Control and Prevention. Bioterrorism alleging use of anthrax and interim guidelines for management. United States; 1998. MMWR. 1999;48:69-74.

• Centers for Disease Control and Prevention. Laboratory-acquired human glanders. Maryland; May 2000. MMWR. 2000;49:532-5.

• Centers for Disease Control and Prevention. Surveillance for adverse events associated with anthrax vaccination. U.S. Dept. of Defense; 1998-2000. MMWR. 2000;49:341-5.

• Centers for Disease Control and Prevention. Suspected brucellosis case prompts investigation of possible bioterrorism-related activity. MMWR. 2000;49:509-12.

• Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM, Jr. Biological warfare. A historical perspective. JAMA. 1997 Aug 6, 278(5):412-7.

• Christopher GW and Eitzen EM Jr. Air evacuation under high-level biosafety containment: The aeromedical isolation team. Emerging Infect Dis. 1999;5:241-246.

• Cole LA. The specter of biological weapons. Scientific American. 1996 Dec;275(6):60-65.

• Dixon TC, Meselson M, Guillemin J, and Hanna PC. Anthrax. New Engl J Med. 1999;341:815-826.

• Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997 Aug 6;278(5):399-411. (Entire JAMA issue on biological terrorism.)

• Friedlander AM, Pittman PR, and Parker GW. Anthrax vaccine: Evidence for safety and efficacy against inhalational anthrax. JAMA. 1999;282:2104-2106.

• Fullerton CS and Ursano RJ. Health care delivery in the high-stress environment of chemical and biological warfare. Military Medicine. 1994 Jul;159(7):524-8.

• Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon. JAMA. 1999;281:2127-37

• Holloway HC, Norwood AE, Fullerton CS, et al. The threat of biological weapons. Prophylaxis and mitigation of psychological and social consequences. JAMA. 1997 Aug 6;278(5):425-7.

• Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: Medical and public health management. JAMA. 1999;281:1735-1745.

• Inglesby TV, et al. Plague as a biological weapon. JAMA. 2000;283:2281-90.

• Institute of Medicine. Improving civilian medical response to chemical or biological terrorist incidents: Interim report on current capabilities. Washington, DC: National Academy Press; 1998.

• Kaufmann AF, Meltzer MI, and Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerging Infect Dis. 1997 Apr-Jun;3(2):83-94.

• Keim M and Kaufmann AF. Principles for emergency response to bioterrorism. Ann Emerg Med. 1999;34:177-182.

• Lebeda FJ. Deterrence of biological and chemical warfare: a review of policy options. Military Medicine. 1997 Mar;162(3):156-61.

• Macintyre AG, Christopher GW, Eitzen E, et al. Weapons of mass destruction events with contaminated casualties: Effective planning for health care facilities. JAMA. 2000;283:242-249. (Commentary p. 252)

• Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I; Shelokov A, and Yampolskaya O. The Sverdlovsk anthrax outbreak of 1979. Science. 1994 Nov 18;266(5188):1202-8.

• Mobley JA. Biological warfare in the twentieth century: lessons from the past, challenges for the future. Military Medicine. 1995 Nov;160(11):547-53.

• Moran GJ. Biological Terrorism Part I. Emergency Medicine. 2000;32(2):14-38.

• Moran GJ. Biological Terrorism Part II. Emergency Medicine. 2000;32(3):110-115.

• Moran GJ. CDC Update Commentary: Bioterrorism alleging use of anthrax and interim guidelines for management. Ann Emerg Med. 1999;34:229-232.

• Noah DL, Sobel AL, Ostroff SM, and Kildew JA. Biological warfare training: infectious disease outbreak differentiation criteria. Military Medicine. 1998 Apr;163(4):198-201.

• Paddle BM. Biosensors for chemical and biological agents of defense interest. Biosensors and Bioelectronics. 1996;11(11):1079-113.

• Pavlin JA. Bioterrorism and the importance of the pubolic health laboratory. Military Medicine. 2000;165(7 supp 2):25-7.

• Proceedings of the National Symposium of Medical and Public Health Response to Bioterrorism. Emerg Infec Dis. 1999;5(4):491-565.

• Richards CF, Burstein JL, Waeckerle JF, and Hutson HR. Emergency physicians and biological terrorism. Ann Emerg Med. 1999;34:183-190.

• Rivkind A, Barach P, Israeli A, Berdugo M, and Richter ED. Emergency preparedness and response in Israel during the Gulf War. Annals of Emergency Medicine. 1997 Oct;30(4):513-21.

• Robertson AG and Robertson LJ. From asps to allegations: biological warfare in history. Military Medicine. 1995 Aug;160(8):369-73.

• Russell PK. Biologic terrorism--responding to the threat. Emerging Infect Dis. 1997 Apr-Jun;3(2):203-4.

• Simon JD. Biological terrorism. Preparing to meet the threat. JAMA. 1997 Aug 6;278(5):428-30.

• Simon JD. Biological terrorism. Preparing to meet the threat. JAMA. 1997 Aug 6;278(5):428-30.

• Steffen R, Mellin J, Woodall JP, Rollin PE, Lang RH, Luthy R, and Waldvogel A. Preparation for emergency relief after biological warfare. Journal of Infection. 1997 Mar; 34(2):127-32.

• Terriff CM and Tee AM. Citywide Pharmaceutical Preparation For Bioterrorism. Am J Health Syst Pharm. 2001;58(03):233-237.

• Tucker JB. National health and medical services response to incidents of chemical and biological terrorism. JAMA. 1997 Aug 6;278(5):362-8.

• Wiener SL. Strategies for the prevention of a successful biological warfare aerosol attack. Military Medicine. 1996 May;161(5):251-6.